4
MARKET OVERVIEW
This section summarizes market dynamics, key shifts, and high-impact trends shaping demand outlook.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE DIABETES CARE DEVICES INDUSTRY
5.2.4
TRENDS IN THE INJECTABLE DRUG DELIVERY INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6
PRICING ANALYSIS (2023-2025)
5.6.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2023-2025)
5.6.2
AVERAGE SELLING PRICE TREND, BY PRODUCT (2023-2025)
5.6.3
AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFFS–GLOBAL INSULIN DELIVERY DEVICES MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.5
IMPACT ON END-USE INDUSTRIES
5.13
REIMBURSEMENT ANALYSIS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON INSULIN DELIVERY DEVICES PROCEDURES
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN INSULIN DELIVERY DEVICES PROCEDURES
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN THE INSULIN DELIVERY DEVICES MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
GLOBAL INSULIN DELIVERY DEVICES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & IN VOLUME, THOUSAND UNITS)
9.2.1
REUSABLE INSULIN PENS
9.2.2
DISPOSABLE INSULIN PENS
9.3.1
TETHERED INSULIN PUMPS
9.3.2
TUBELESS INSULIN PUMPS
9.4.1
STANDARD INSULIN PEN NEEDLES
9.4.2
SAFETY INSULIN PEN NEEDLES
9.6
OTHER INSULIN DELIVERY DEVICES
10
GLOBAL INSULIN DELIVERY DEVICES MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
11
GLOBAL INSULIN DELIVERY DEVICES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
11.2
SELF/HOME HEALTHCARE
11.3
HOSPITALS & DIABETES SPECIALTY CLINICS
12
GLOBAL INSULIN DELIVERY DEVICES MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & IN VOLUME, THOUSAND UNITS)
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.7
REST OF ASIA PACIFIC
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.4
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.3
REST OF MIDDLE EAST & AFRICA
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
13.3
REVENUE SHARE ANALYSIS (2021-2025)
13.4
MARKET SHARE ANALYSIS (2025)
13.5
BRAND & PRODUCT COMPARATIVE ANALYSIS
13.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.6.5.1
COMPANY FOOTPRINT
13.6.5.2
REGION FOOTPRINT
13.6.5.3
PRODUCT FOOTPRINT
13.6.5.4
APPLICATION FOOTPRINT
13.6.5.5
END-USER FOOTPRINT
13.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.7.1
PROGRESSIVE COMPANIES
13.7.2
RESPONSIVE COMPANIES
13.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.8
COMPANY VALUATION AND FINANCIAL METRICS
13.9
COMPETITIVE SCENARIO
14.1.1
EMBECTA CORP. (FORMERLY BD DIABETES CARE BUSINESS)
14.1.6
YPSOMED HOLDINGS AG
14.1.7
TANDEM DIABETES CARE, INC
14.1.8
INSULET CORPORATION
14.1.10
ROCHE DIABETES CARE
14.1.11
TERUMO CORPORATION
14.1.12
NIPRO CORPORATION
14.1.14
MANNKIND CORPORATION
14.1.15
WOCKHARDT LIMITED
14.2.3
MEDTRUM TECHNOLOGIES
14.2.4
HINDUSTAN SYRINGES & MEDICAL DEVICES LTD
14.2.5
HASELMEIER GMBH, A MEDMIX LTD COMPANY
14.2.6
SOOIL DEVELOPMENT CO., LTD.
14.2.9
JIANGSU DELFU MEDICAL DEVICE CO., LTD
14.2.10
SUNGSHIM MEDICAL CO., LTD.
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
KEY PRIMARY PARTICIPANTS
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.4
KEY INDUSTRY INSIGHTS
15.2
MARKET SIZE ESTIMATION
15.2.1
BOTTOM-UP APPROACH
15.2.3
BASE NUMBER CALCULATION
15.3
MARKET FORECAST APPROACH
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Insulin Delivery Devices Market